News

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...
Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it would be irreversibly tragic.
The capped upside and unlimited downside risk make MRNY unattractive unless Moderna's share price stabilizes and recovers ...
When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...
Traditionally, COVID vaccines have been delivered via injections. According to the Cincinnati Children’s Hospital Medical ...
Many Indian firms chase quick returns, rely on imported technology, and underinvest in research. But innovation needs ...
For decades, one of the world’s most contagious diseases was considered eradicated in the U.S. But now measles is roaring back.
Eli Lilly (NYSE: LLY) led the way in pharma M&A during June. The US pharma major announced two major deals in the month, both ...
The administration’s assault on innovation extends beyond funding cuts — it is also actively chasing away the talent that ...
Candida, a type of fungus, which can spread throughout the body via the bloodstream, leading to organ damage and sepsis.
The U.S. Centers for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu outbreak, a move ...